Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Robert Cohen who wrote (1370)	5/29/2001 9:25:00 AM
From: dalroi	Respond to of 1477

Scio buyable preopening for only 27.90$ and droppping cheers stefaan

To: Robert Cohen who wrote (1370)	5/29/2001 8:05:08 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 1477

<<For example, in the treatment of acute myocardial infarction (heart attack)the decision to use thrombolytic therapy is based ONLY on the indications for its use not on the ability of the patient to pay or the type of insurance coverage. In my 20+ years of practice I have never been approached by hospital administrators or another physician to alter my treatment based on economic issues.>> Yes, right! And, what is first question that administrator ask person when he enter hospital? <<NTG is in fact safe and effective and cheap.>> NTG is only cheap! If it is effective and safe it will not be cheap! It is not safe and efficacy is questionable. However there was nothing better, so it was use as only choice. Miljenko